Perceptive LIFE Sciences Master FUND Ltd., 10% Owner at Aldeyra Therapeutics, Inc. (ALDX), bought 824,812 shares at $5.59 ($4.6M) on 2022-08-02, disclosed to the SEC on 2022-08-04.
Open-market purchase of $4.6M ALDX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.59 | 412,406 | $2.3M | 50.0% |
| 2 | $5.59 | 412,406 | $2.3M | 50.0% |
| Total | $5.59 avg | 824,812 | $4.6M | 100% |
| Filing → |
| ACRV | BUY | 2024-04-15 | $20.0M | — | Filing → |
| ALDX | BUY | 2024-04-03 | $3.8M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |